Reports and Accounting. 8.1. The Company shall give Yissum written notice of any Milestone achieved, Sublicense Consideration received or First Commercial Sale made within 30 days of such event.
Appears in 1 contract
Samples: Research and License Agreement (Immune Pharmaceuticals Inc)
Reports and Accounting. 8.1. 8.1 The Company shall give Yissum written notice of any Milestone achieved, Sublicense Consideration received or First Commercial Sale made within 30 thirty (30) days of such event.
Appears in 1 contract
Samples: Research Agreement (Environmental Impact Acquisition Corp)
Reports and Accounting. 8.1. The Company shall give Yissum written notice of any Milestone achieved, Sublicense Consideration received or First Commercial Sale made within 30 days of such event.
Appears in 1 contract
Samples: Research and License Agreement (Immune Pharmaceuticals Inc)
Reports and Accounting. 8.1. The Company shall give Yissum written notice of any Milestone achieved, Sublicense Consideration received or First Commercial Sale made within 30 thirty (30) days of such event.
Appears in 1 contract
Samples: License Agreement (Kitov Pharmaceuticals Holdings Ltd.)
